Entera Accounts Payable from 2010 to 2024

ENTX Stock  USD 1.64  0.06  3.53%   
Entera Bio Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 78.8 K in 2024. Accounts Payable is the amount Entera Bio owes to suppliers or vendors for products or services received but not yet paid for. It represents Entera Bio's short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2015-12-31
Previous Quarter
69 K
Current Value
184 K
Quarterly Volatility
291.9 K
 
Yuan Drop
 
Covid
Check Entera Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Entera Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 97.3 K, Interest Expense of 31.4 M or Selling General Administrative of 5.2 M, as well as many indicators such as Price To Sales Ratio of 79.86, Dividend Yield of 0.0 or PTB Ratio of 1.76. Entera financial statements analysis is a perfect complement when working with Entera Bio Valuation or Volatility modules.
  
Check out the analysis of Entera Bio Correlation against competitors.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

Latest Entera Bio's Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of Entera Bio over the last few years. An accounting item on the balance sheet that represents Entera Bio obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Entera Bio are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Entera Bio's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Entera Bio's overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Slightly volatile
   Accounts Payable   
       Timeline  

Entera Accounts Payable Regression Statistics

Arithmetic Mean271,390
Geometric Mean198,039
Coefficient Of Variation61.94
Mean Deviation142,199
Median351,000
Standard Deviation168,093
Sample Variance28.3B
Range579K
R-Value(0.58)
Mean Square Error20.2B
R-Squared0.34
Significance0.02
Slope(21,779)
Total Sum of Squares395.6B

Entera Accounts Payable History

202478.8 K
202383 K
202217 K
2021166 K
2020164 K
2019334 K
2018473 K

About Entera Bio Financial Statements

Entera Bio investors use historical fundamental indicators, such as Entera Bio's Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Entera Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable83 K78.8 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Entera Stock Analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.